Other
Change in Other Liabilities
Amgen Change in Other Liabilities increased by 1.3% to -$75.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.8%, from -$78.00M to -$75.00M. Over 3 years (FY 2021 to FY 2025), Change in Other Liabilities shows a downward trend with a 50.6% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Fluctuations are often driven by non-operating events or accounting adjustments rather than core business performance.
Detailed definition
This metric tracks the net change in miscellaneous short-term or long-term liabilities that are not classified as accoun...
Peer comparison
Standard line item in the cash flow statement for most large corporations.
Metric ID:
anet_change_in_other_liabilitiesHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $402.00M | $99.00M | -$267.00M | -$396.00M | $440.00M | $419.00M | -$645.00M | -$78.00M | -$44.00M | -$28.00M | -$72.00M | -$56.00M | -$39.00M | -$78.00M | $0.00 | -$10.00M | -$76.00M | -$75.00M |
| QoQ Change | — | -75.4% | -369.7% | -48.3% | +211.1% | -4.8% | -253.9% | +87.9% | +43.6% | +36.4% | -157.1% | +22.2% | +30.4% | -100.0% | +100.0% | — | -660.0% | +1.3% |
| YoY Change | — | — | — | — | +9.5% | +323.2% | -141.6% | +80.3% | -110.0% | -106.7% | +88.8% | +28.2% | -39.3% | -39.3% | — | +74.4% | — | +3.8% |
Range-$645.00M – $440.00M
CAGR-32.6%
Avg YoY Growth+14.3%
Median YoY Growth+6.6%
Change in Other Liabilities at Other Companies
Frequently Asked Questions
- What is Amgen's change in other liabilities?
- Amgen (AMGN) reported change in other liabilities of -$75.00M in Q1 2026.
- How has Amgen's change in other liabilities changed year-over-year?
- Amgen's change in other liabilities increased by 3.8% year-over-year, from -$78.00M to -$75.00M.
- What is the long-term trend for Amgen's change in other liabilities?
- Over 3 years (2021 to 2025), Amgen's change in other liabilities has grown at a 50.6% compound annual growth rate (CAGR), from -$48.00M to -$164.00M.
- What does change in other liabilities mean?
- The net change in miscellaneous liabilities not categorized elsewhere.